The Central American Bank for Economic Integration (CABEI) has approved $105,000 in technical funding to enhance regional healthcare systems. This financial support targets Phase II of the comprehensive feasibility study for a regional manufacturing plant. Furthermore, the facility will produce essential biological products and modern medications to safeguard public health across the area.
Developing a Feasibility Framework for Local Biological Manufacturing
The Regional Center for Research on Vaccines and Biopharmaceuticals (CRIVB) leads this initiative in coordination with Panama’s National Secretariat of Science, Technology, and Innovation (SENACYT). Through this funding, specialized teams will execute comprehensive technical, economic, environmental, and financial assessments.
Consequently, these rigorous analyses will determine the total viability of the proposed facility. The projected manufacturing site aims for an operational capacity of up to 30 million doses per year. Therefore, establishing regional biopharmaceutical manufacturing will directly reduce reliance on extra-regional imports while strengthening fast-response capabilities against future global sanitary crises.
Strengthening Health Security in Central America Through Scientific Innovation
Building local capacity for Central American vaccine manufacturing represents a monumental step toward long-term medical self-sufficiency. Key leaders attended the official announcement in Panama City, including Foreign Minister Javier Martínez-Acha, Health Minister Fernando Boyd Galindo, and SENACYT National Secretary Dr. Eduardo Ortega Barría.
Additionally, CABEI Country Manager Mauricio Chacón and CRIVB Director Dr. Paulina Franceschi emphasized the importance of institutional alignment. They noted that scientific innovation in Panama serves as a major driver for continental health sovereignty. By leveraging cutting-edge research and cross-border cooperation, regional partners can protect populations more effectively.
Fostering Long-Term Cooperation via CABEI Technical Assistance
Ultimately, CABEI technical assistance reinforces sustainable development across member countries. Supporting high-impact infrastructure allows the institution to promote scientific research, tech transfer, and health resilience. As a result, Central America and the Caribbean take a decisive step toward biological manufacturing independence and future pandemic readiness.
